Mankind Pharma P/B Ratio
Mankind Pharma (MANKIND) P/B ratio is 6.5 (High), book value per share ₹4039.27 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. Review MANKIND P/E comparison to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MANKIND P/B Ratio — Valuation Insights & Book Value Analysis
Mankind Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 6.5 (High). View MANKIND annual price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 6.5, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 647.1% above historical average
- Trading at premium to sector average PB of -0.31
Mankind Pharma P/B Ratio Historical Trend
MANKIND annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see MANKIND share price screener.
MANKIND Historical P/B Ratio — Book Value Per Share & Year-End Price
Mankind Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.62 | ₹4039.27 | ₹2507.20 | ₹16,561 | Low |
| 2025 | 0.62 | ₹3553.17 | ₹2196.50 | ₹14,568 | Low |
| 2024 | 1.2 | ₹2394.0 | ₹2880.40 | ₹9,576 | Moderate |
| 2023 | 1.04 | ₹1905.75 | ₹1982.50 | ₹7,623 | Moderate |
MANKIND vs Healthcare Peers — P/B Ratio Comparison
Mankind Pharma P/B 6.5 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |